Drawing for MAI RUI SHU

USPTO serial 75200361

MAI RUI SHU

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
POWERS, ALEXANDER L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MAI RUI SHU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

HOLLY M FORD

HOLLY M FORD BURNS DOANE SWECER & MATHIS LLPP O BOX 1404ALEXANDRIA, VA 22313-1404UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for preventing the cells with cancerous genes from cross-linking and integrating with virus of cancerous genes, thus aiming to avoid and resist cancer; veterinary preparations for increasing the immune cell's activity, strengthening immunity of organism, restraining and killing cancer cells; sanitizers for household use; biological pharmaceutical preparations for releasing the pain caused by chemotherapy to help the patient finish the treatment successfully; food and beverages for medically restricted diets; baby food; vegetable, herbal and animal extracts for medical and slimming purposes sold as an integral component of soft drinks, teas, and tonics; meal replacement and dietary supplement drink mixesABANDONED—
032mineral and aerated water; soft drinks; sports drinks; fruit drinks; fruit juices; concentrates, syrups or powders used in the preparation of soft drinksABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 26, 1998ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 9, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 1997CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 14, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 1997DOCKASSIGNED TO EXAMINER—
Jun 6, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance